QI Academy

Helping make future leaders.

The BSH QI Academy is dedicated to mentoring and supporting heart failure nurses and allied health professionals to become future leaders.

We believe having access to quality improvement resources will support specialists in improving patient outcomes and create value for the wider health economy.

Find out about our Nurse Forum’s bespoke quality improvement programme, in association with EQE Health.

Be part of the British Society for Heart Failure and EQE Health QI Academy 2026/27 Cohort

Learn about the QI Academy

Becky Hyland, British Society for Heart Failure Nurse Forum

“Quality improvement is at the heart of the QI Academy initiative. We want to inspire, nurture and champion the role of nurses in diagnosing and treating heart failure. Together, we can mobilise our nursing workforce to become innovators in heart failure care”

Aims of the QI Academy

  • To provide a grounding in quality improvement methodology.

  • To support participants to undertake a quality improvement initiative within their services.

  • To demonstrate the feasibility of quality improvement methodology for the evaluation of person-centred care and services by individuals or groups.

  • To demonstrate how quality improvement projects highlight the local application of international, national, and local policies and guidelines.

  • To support each participant to undertake a quality improvement project within one year of programme inception.

Impact of past QI Academy projects

  • Improved health equity, understanding and accessibility for people with heart failure

  • Increased awareness of heart failure

  • Reduced admissions and better management

  • Increased screening/earlier diagnostics and early initiation of medical therapy

  • Prevention of deterioration of those with established heart failure, including secondary prevention through cardiac rehabilitation

  • Identification of undiagnosed and poorly managed diabetes

Boehringer Ingelheim have provided funding towards this education programme. Boehringer Ingelheim has had no editorial input into or influence on the agenda, collateral content of the meetings including the selection of speakers.